Chromium nicotinate

DB14529ApprovedSmall moleculeNicotinic Acids

Chromium nicotinate is a medication used to treat chromium deficiencies and associated symptoms and also in total parenteral nutrition.

Chemical structure of Chromium nicotinate
Mechanism
Curator reviewed · 6 references
Primary indication
Indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (TPN), to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.Curator reviewed
Formula / weight
C18H12CrN3O6 · 418.305 g/mol (avg)
First approval
United States, 2015
Also known as
Chromium(III) nicotinate

Resolves to

Clinical / RWD
Structure
InChIKeyMSPQQAUTCRWLGR-UHFFFAOYSA-KSMILES[Cr+3].[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1.[O-]C(=O)C1=CN=CC=C1

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
726Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
32Marketed productsAcross 2 countries and 7 labellers
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Chromium nicotinate, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account